Guided Therapeutics (GTHP) Shares Issued (2011 - 2025)

Guided Therapeutics has disclosed Shares Issued across 14 years of filings, most recently posting $307000.0 for Q4 2025.

• Shares Issued for Q4 2025 came in at $307000.0, down 42.62% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.1 million (up 36.77% YoY), and the FY2025 annual result was $567000.0, down 32.1% from the prior year.
• Shares Issued came in at $307000.0 for Q4 2025 at Guided Therapeutics, down from $535000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $1.8 million in Q2 2021 to a low of -$1.8 million in Q3 2021.
• The 5-year median for Shares Issued is $300000.0 (2024), against an average of $191818.2.
• Across the five-year window, Shares Issued surged 6920.0% in 2021 and tumbled 92.59% in 2022, its largest moves.
• Guided Therapeutics' Shares Issued stood at -$1.8 million in 2021, then soared by 102.11% to $37000.0 in 2022, then surged by 1078.38% to $436000.0 in 2023, then grew by 22.71% to $535000.0 in 2024, then sank by 42.62% to $307000.0 in 2025.
• The last three Shares Issued figures came in at $307000.0 (Q4 2025), $535000.0 (Q4 2024), and $300000.0 (Q3 2024), per Business Quant data.